TY - JOUR
T1 - Multiple increased osteoclast functions in individuals with neurofibromatosis type 1
AU - Stevenson, David A.
AU - Yan, Jincheng
AU - He, Yongzheng
AU - Li, Huijie
AU - Liu, Yaling
AU - Zhang, Qi
AU - Jing, Yongmin
AU - Guo, Zhiping
AU - Zhang, Wei
AU - Yang, Dalong
AU - Wu, Xiaohua
AU - Hanson, Heather
AU - Li, Xiaohong
AU - Staser, Karl
AU - Viskochil, David H.
AU - Carey, John C.
AU - Chen, Shi
AU - Miller, Lucy
AU - Roberson, Kent
AU - Moyer-Mileur, Laurie
AU - Yu, Menggang
AU - Schwarz, Elisabeth L.
AU - Pasquali, Marzia
AU - Yang, Feng Chun
PY - 2011/5
Y1 - 2011/5
N2 - Skeletal abnormalities including scoliosis, tibial dysplasia, sphenoid wing dysplasia, and decreased bone mineral density (BMD) are associated with neurofibromatosis type 1 (NF1). We report the cellular phenotype of NF1 human-derived osteoclasts and compare the in vitro findings with the clinical phenotype. Functional characteristics (e.g., osteoclast formation, migration, adhesion, resorptive capacity) and cellular mechanistic alterations (e.g., F-actin polymerization, MAPK phosphorylation, RhoGTPase activity) from osteoclasts cultured from peripheral blood of individuals with NF1 (N=75) were assessed. Osteoclast formation was compared to phenotypic, radiologic, and biochemical data. NF1 osteoprogenitor cells demonstrated increased osteoclast forming capacity. Human NF1-derived osteoclasts demonstrated increased migration, adhesion, and in vitro bone resorption. These activities coincided with increased actin belt formation and hyperactivity in MAPK and RhoGTPase pathways. Although osteoclast formation was increased, no direct correlation of osteoclast formation with BMD, markers of bone resorption, or the clinical skeletal phenotype was observed suggesting that osteoclast formation in vitro cannot directly predict NF1 skeletal phenotypes. While NF1 haploinsufficiency produces a generalized osteoclast gain-in-function and may contribute to increased bone resorption, reduced BMD, and focal skeletal defects associated with NF1, additional and perhaps local modifiers are likely required for the development of skeletal abnormalities in NF1.
AB - Skeletal abnormalities including scoliosis, tibial dysplasia, sphenoid wing dysplasia, and decreased bone mineral density (BMD) are associated with neurofibromatosis type 1 (NF1). We report the cellular phenotype of NF1 human-derived osteoclasts and compare the in vitro findings with the clinical phenotype. Functional characteristics (e.g., osteoclast formation, migration, adhesion, resorptive capacity) and cellular mechanistic alterations (e.g., F-actin polymerization, MAPK phosphorylation, RhoGTPase activity) from osteoclasts cultured from peripheral blood of individuals with NF1 (N=75) were assessed. Osteoclast formation was compared to phenotypic, radiologic, and biochemical data. NF1 osteoprogenitor cells demonstrated increased osteoclast forming capacity. Human NF1-derived osteoclasts demonstrated increased migration, adhesion, and in vitro bone resorption. These activities coincided with increased actin belt formation and hyperactivity in MAPK and RhoGTPase pathways. Although osteoclast formation was increased, no direct correlation of osteoclast formation with BMD, markers of bone resorption, or the clinical skeletal phenotype was observed suggesting that osteoclast formation in vitro cannot directly predict NF1 skeletal phenotypes. While NF1 haploinsufficiency produces a generalized osteoclast gain-in-function and may contribute to increased bone resorption, reduced BMD, and focal skeletal defects associated with NF1, additional and perhaps local modifiers are likely required for the development of skeletal abnormalities in NF1.
KW - Bone mineral density
KW - Bone resorption
KW - Neurofibromatosis type 1
KW - Osteoporosis
KW - Ras
UR - http://www.scopus.com/inward/record.url?scp=79955007125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955007125&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.33965
DO - 10.1002/ajmg.a.33965
M3 - Article
C2 - 21465658
AN - SCOPUS:79955007125
SN - 1552-4825
VL - 155
SP - 1050
EP - 1059
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 5
ER -